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H. L. Jakobsen*, N. Baekgaard and J. K. Christoffersen 
Vascular section, Gentofle University Hospital, Denmark 
Objectives: To determine the value of PTFE grafts with a distal vein cuff as a conduit for below-knee (BK) popliteal 
and distal bypass in the absence of autologous vein. 
Design: Retrospective study. 
Materials and methods: Forty below BK popliteal and distal bypass procedures in 39 patients with PTFE and distal 
vein cuff (Miller cuff n = 31, Wolfe cuff and adjuvant arteriovenous fistula n = 9). Nineteen primary and 21 secondary 
reconstruction procedures. 
Results: The primary patency rate was 62, 5% at 1 year falling to 50% at 2 years. The secondary patency rates were 
ven d similar owing to poor outcome of thrombectomy. Ten cases (25%) resulted in major amputation postoperatively. 
There was a tendency towards better outcome for primary procedures compared to secondary~redo pr cedures. 
Conclusions: BK popliteal and distal bypass with PTFE and distal vein cuff is a worthwhile procedure in the absence 
of autologous vein. The value of thrombectomy following thrombosis of a secondary bypass procedure with PTFE and 
distal vein cuff is questionable. 
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Introduction 
Autologous vein remains the best available conduit 
for femorodistal bypass procedures. When autologous 
vein is either not available or unsuitable, a prosthetic 
graft must be used for the bypass procedure. Expanded 
polytetrafluoroethylene (PTFE) was introduced in the 
1970s for clinical use as small-calibre arterial sub- 
stitute. 2'3 Although grafting with PTFE produces ac- 
ceptable results for above-knee femoropopliteal 
reconstructions, 1'44 its use remains controversial for 
femorodistal bypass procedures. Due to unsatisfactory 
patency rates achieved with PTFE for femorodistal 
grafting, 7-9 some surgeons have suggested that primary 
amputation should be considered if autologous vein 
is unavailable. 1° However, if acceptable limb salvage 
rates are achieved, femorodistal grafting is eco- 
nomically viable. 11-14 Some modifications have been 
suggested to optimise patency, and interposition of a 
vein cuff at the distal anastomosis was first described 
by Siegmann in 1979.15 The technique was further 
developed by Miller, 16 who reported promising early 
clinical results in 1984 and later by Tyrrell and 
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Wolfe. 17'18 The cuff was originally employed to facilitate 
the technically demanding distal anastomosis, but pre- 
liminary results from a randomised trial comparing 
PTFE grafts with and without Miller cuff show a clear 
advantage for the Miller cuff 19 A modification of the 
venous cuff technique, with construction of an ad- 
juvant arteriovenous fistula at or close to the distal 
anastomosis has been proposed to enhance patency, 
theoretically by augmentation f blood flow through 
the prostetic graft, a° 
In the absence of a suitable vein we have used a 
PTFE graft with vein cuff for below-knee (BK) popliteal 
and distal reconstruction for more than 5 years. The 
purpose of the present paper was to describe our 
results with this technique. 
Material and Methods 
We performed 40 BK popliteal and distal bypass pro- 
cedures with thin-wall, ring-supported PTFE and 
distal vein cuff in 39 patients from October 1990 to 
January 1996. There were 17 men and 22 women with 
a mean age of 74.5 years (range 55-88 years). The 
indication for surgery was critical ischaemia in all 
cases. Three patients had diabetes mellitus. We per- 
formed 19 primary procedures inwhich the saphenous 
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vein was absent or unsuitable due to previous urgery 
or thrombosis, and 21 secondary grafting procedures, 
in which the saphenous vein had been used for in situ 
bypass to the same segment. Interposition of a Miller 
cuff was used in 31 procedures, the remainder had a 
Wolfe cuff with adjuvant arteriovenous fistula per- 
formed. The selection of distal cuff-type was arbitrary. 
For anticoagulation all patients received extran per- 
operatively. Postoperatively we used low molecular 
weight heparin (LMWH) in two cases (5%), Dextran 
in 15 cases (37, 5%) and vitamin K antagonist in the 
last 23 cases (57, 5%). LMWH and Dextran was only 
used during hospitalisation, while vitamin k-an- 
tagonist reatment was continued after the discharge 
from hospital. The level of distal anastomosis was to 
the distal popliteal in eight cases (20%), of which two 
cases had run-off via three patient crural vessels, four 
cases had two patent and the last two cases only one 
patent crural vessel. The tibioperoneal trunk (TP) was 
used in two cases (5%) with a two and one crural 
vessel run-off, respectively. The anterior tibial artery 
was utilised in three cases (7, 5%), posterior tibial 
artery in 12 (29%) and the peroneal artery in the 
remaining 15 cases (37, 5%). 
All patients were followed by regular clinical ex- 
amination and recording of ankle:brachial index. In 
case of graft occlusion, thrombectomy was performed. 
Further arteriography was not performed if re- 
occlusion occurred following thrombectomy, since the 
patient then was considered inoperable. All results 
were subjected to life-table analysis, and statistical 
analysis was performed by the log-rank test. 
Results 
Ten patients (26%) died during the study period. Four 
of these died in early postoperative period (<30 days) 
as a consequence of vascular disease; two as sequelae to 
contemporaneous aorta surgery. The primary patency 
(Fig. 1) was 82.5% at 1 month, falling to 62.5% at 
1 year and 50% at 2 years. Thrombectomy was per- 
formed in 12 cases, four within the early postoperative 
period and eight in the late postoperative period. 
Thrombectomy was, however, only successful in one 
case; the remaining 11 reoccluded. Five of the thromb- 
ectomies were performed after a primary re- 
construction and seven following a secondary 
reconstruction. Reocclusion following thrombectomy 
resulted in five amputations, all of which occurred in 
the secondary reconstruction group. The secondary 
patency rate was not very different from the primary 
patency rate, 82.5% at 1 month falling to 62.5% at 
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Fig. 1. Pr imary patency in BK popliteal and distal PTFE bypass 
with distal vein cuff. The secondary patency rates were almost 
identical and are not shown. Numbers  at risk are shown at each 
time interval. (~) Patency. 
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Fig. 2. Limb salvage rate of BK popliteal and distal PTFE bypass 
with distal vein cuff. Numbers  at risk are shown at each time 
interval. (~) Limb salvage. 
1 year and 52.5% at 2 years. Ten cases (25%) resulted 
in major amputation postoperatively, and the limb 
salvage curve is shown in Fig. 2. One year salvage 
rate was 80% and 75% at 2 years. Except for the 
primary patency rate at 1 month, where the Vitamin- 
K antagonist treated group had a superior patency, no 
differences were found with regard to antithrombotic 
treatment. When comparing primary reconstructions 
to secondary/redo reconstructions, primary patency 
rates (Fig. 3) were higher for the secondary re- 
construction group at 1 month, but 1 and 2 years' 
patency showed a tendency towards better outcome 
in the primary group (i.e. 74% and 63%, respectively), 
compared with i and 2 years' patency of, respectively, 
48% and 38% in the secondary reconstruction group. 
However, the sample size was small and not significant 
Eur J Vasc Endovasc Surg Vol 15, April 1998 
PTFE  Bypass  and  D is ta l  Ve in  Cuf f  329 
100, 
90 
80 
70 
60 
o 
o 50 
~ 40-  
30 
20 
10 
0 
1716 
7 i 
1 _ I = , 
2 ! A v v 
I I I I I I I I I r I I r I 
3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 
Months 
Fig. 3. Primary patency rates for Primary and Secondary procedures 
in BK popliteal nd distal PTFE bypass with vein cuff. Numbers at 
risk are shown at each time interval. (II,) Redo; (I) primary. 
(p>0,1). The distal popliteal and tibioperoneal trunk 
combined achieved the best patency rates at 1 year; 
80% compared to 60% for the peroneal artery, 50% for 
the posterior and 34% for the anterior tibial artery. 
Two year patency rates were however Similar for the 
distal popliteal and TP group and the peroneal artery 
(60%). For the anterior and posterior tibial artery 2- 
year patency rates of only 34% and 33% were achieved. 
But again, sample size was small and not significant 
(p>0,2). 
Comparing the Miller to the Wolfe cuff with adjuvant 
arteriovenous fistula, 1-year patency rates were 59% 
and 67%, and 2-year patency rates 49% and 56%, 
respectively (p>0,2). 
Discuss ion  
We think that he 1-year patency rate of 62.5% achieved 
in this study for BK popliteal and distal reconstruction 
is acceptable and compares favourably to the patency 
rates found by Tyrell and Miller, i.e. 40% and 51%, 
respectively. 17'21 We also think that our limb salvage 
rate of 80% at 1 year is acceptable and comparable to 
other studies with limb salvage rates between 65- 
74%. 17'2°'2~ The mean patient age in this study is very 
similar to, or even a little higher than in other 
studies. 16"~7'2° The perioperative mortality rate of 10% 
(four patients) in this study was influenced by the fact 
that two patients underwent aortic surgery at the same 
time as the distal bypass procedure, which places these 
patients in a higher isk group. The two other patients 
did not differ from the remaining patients with regard 
to age, cardio-vascular disease or severity of disease. 
In our study, early thrombosis occurred in 20% of the 
procedures, a relative high percentage, but comparable 
to other studies (13-21%). 17'2° We have no specific 
explanation for the high percentage of early graft 
thrombosis, which is probably due to the severity of 
arteriosclerotic disease in these patients. Miller claimed 
that the presence of a venous cuff facilitated later 
thrombectomy, 16 and a 40% success rate for throm- 
bectomy in the early postoperative period has been 
described. 17However, in our study only one graft out 
of 12 had a successful thrombectomy, and rethrombosis 
in the redo-group resulted in an amputation rate of 
71%, which raises the question of whether throm- 
bectomy for thrombosis of a secondary reconstruction 
is a worthwhile procedure. As described in other 
studies, 10-25% of patients are able to tolerate oc- 
clusion of a reconstruction, even if the operation was 
performed for limb salvage. 22'23 This proportion seems 
to increase with the time interval between the primary 
operation and failure. Our study seems to confirm this 
tendency, with a limb salvage rate of 75% at 2 years. 
Twenty-five per cent of the cases required major am- 
putation, and 80% of these were following a secondary 
procedure. Neither age nor severity of limb ischaemia 
helped to identify the patients with poorer outcome. 
Interposition of a vein cuff at the distal anastomosis 
was originally employed to facilitate accurate suturing 
without distortion or stenosing the recipient artery, 16 
and in addition, the presence of distal vein cuff reduces 
the anastomotic myointimal hyperplasia, which is re- 
sponsible for approximately one-third of all PTFE graft 
failures. 24 Examination of occluded Miller cuffs have 
shown that the myointimal hyperplasia is restricted 
to the cuff, and that the recipient artery remains patent 
and free from myointimal hyperplasia. 25 Thus the zone 
of myointimal hyperplasia is removed from the very 
small recipient artery to a point in which the cross- 
sectional area is considerable greater. An explanation 
may be that interposition of a vein cuff reduces the 
compliance mismatch between a rigid PTEE graft and 
an artery, hereby reducing the hyperplasia. 26 Another 
theory is that he special flow-pattern i the cuff causes 
high shear stresses on the arterial wall, which suppress 
the formation of myointimal hyperplasiaY Another 
theory is that the vein cuff increases total graft flow 
by acting as an elastic reservoir. However, ex- 
perimental data comparing PTFE alone to PTFE with 
vein cuff, has not been able to show any increased 
graft flow due to the cuff. 2s 
In conclusion, BK popliteal and distal bypass with 
PTFE and distal vein cuff for critical ischaemia in 
the absence of autologous vein results in acceptable 
patency rates. There is a tendency towards econdary 
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procedures resulting in a poorer outcome than primary 
procedures, and thrombectomy following occlusion 
of a secondary bypass procedure is of questionable 
benefit. 
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